source
- Bausch + Lomb CEO Brent Saunders exits again, interim CEO Thomas Appio appointedBausch + Lomb announced that CEO Brent Saunders is leaving the eye health company for a second time, less than four years into his latest tenure. The departure was mutually agreed upon by Saunders…
- Lakefront Biotherapeutics sells its cell therapy pipeline to Belgian biotech Armed Cell TherapeuticsLakefront Biotherapeutics, formerly known as Galapagos Therapeutics, announced that it has sold its cell therapy pipeline to fellow Belgian biotech Armed Cell Therapeutics. The transferred assets…